Financial Review: Aclarion (NASDAQ:ACONW) and Health Catalyst (NASDAQ:HCAT)

Health Catalyst (NASDAQ:HCAT) and Aclarion (NASDAQ:ACONW) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, risk, earnings, profitability, analyst recommendations, dividends and valuation.

Insider and Institutional Ownership

85.0% of Health Catalyst shares are held by institutional investors. 19.4% of Health Catalyst shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Profitability

This table compares Health Catalyst and Aclarion’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Health Catalyst	-90.61%	-1.83%	-0.80%
Aclarion	N/A	N/A	N/A

Analyst Recommendations

This is a summary of recent ratings for Health Catalyst and Aclarion, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Health Catalyst	1	8	4	0	2.23
Aclarion	0	0	0	0	0.00

Health Catalyst presently has a consensus target price of $2.82, suggesting a potential upside of 73.17%. Given Health Catalyst’s stronger consensus rating and higher probable upside, analysts plainly believe Health Catalyst is more favorable than Aclarion.

Valuation & Earnings

This table compares Health Catalyst and Aclarion”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Health Catalyst	$292.25 million	0.42	-$177.97 million	($3.68)	-0.44
Aclarion	$83,769.00	N/A	N/A	N/A	N/A

Aclarion has lower revenue, but higher earnings than Health Catalyst.

Summary

Health Catalyst beats Aclarion on 6 of the 9 factors compared between the two stocks.

About Health Catalyst

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.

About Aclarion

Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.